Literature DB >> 24076549

Risk factors and organ involvement of chronic GVHD in Japan.

J Kanda1, H Nakasone1, Y Atsuta2, T Toubai3, H Yokoyama4, T Fukuda5, S Taniguchi6, K Ohashi7, H Ogawa8, T Eto9, K Miyamura10, Y Morishima11, T Nagamura-Inoue12, H Sakamaki7, M Murata13.   

Abstract

Few studies have evaluated the risk factors for chronic GVHD and organ involvement associated with different graft types, including unrelated cord blood (U-CB). We retrospectively studied 4818 adult patients who received their first allogeneic transplantation and survived for at least 100 days. The incidence of chronic GVHD at 2 years was 37%. The following factors were associated with the development of chronic GVHD: female donor/male recipient, CMV-Ab seropositivity, matched related peripheral blood grafts vs matched related BM grafts, no in vivo T-cell depletion and the occurrence of grade II-IV acute GVHD. Among these factors, the association with acute GVHD occurrence was consistently significant across donor subtypes. The use of U-CB was not associated with chronic GVHD, but was associated with a low incidence of extensive chronic GVHD. Chronic GVHD patients who had received U-CB transplants showed less frequent involvement of the oral cavity (28% vs 55%), eye (12% vs 26%), liver (20% vs 44%), lung (11% vs 25%) and joint (0% vs 6%) than those with matched related BM grafts. In conclusion, we found that U-CB transplants were associated with a low incidence of extensive chronic GVHD and less frequent involvement of the oral cavity, eye, liver, lung and joints.

Entities:  

Mesh:

Year:  2013        PMID: 24076549     DOI: 10.1038/bmt.2013.151

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  37 in total

Review 1.  Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

Authors:  K M Sullivan; E Agura; C Anasetti; F Appelbaum; C Badger; S Bearman; K Erickson; M Flowers; J Hansen; T Loughran
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

2.  Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction.

Authors:  J Kanda; T Ichinohe; S Kato; N Uchida; S Terakura; T Fukuda; M Hidaka; Y Ueda; T Kondo; S Taniguchi; S Takahashi; T Nagamura-Inoue; J Tanaka; Y Atsuta; K Miyamura; Y Kanda
Journal:  Leukemia       Date:  2012-07-18       Impact factor: 11.528

Review 3.  Chronic graft-versus-host disease in the era of reduced-intensity conditioning.

Authors:  D S Subramaniam; D H Fowler; S Z Pavletic
Journal:  Leukemia       Date:  2007-03-22       Impact factor: 11.528

4.  The significance of oral mucosal and salivary gland pathology after allogeneic bone marrow transplantation.

Authors:  T D Horn; E B Rest; Y Mirenski; R L Corio; M L Zahurak; G B Vogelsang
Journal:  Arch Dermatol       Date:  1995-08

5.  Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.

Authors:  Takayuki Sato; Tatsuo Ichinohe; Junya Kanda; Kouhei Yamashita; Tadakazu Kondo; Takayuki Ishikawa; Takashi Uchiyama; Akifumi Takaori-Kondo
Journal:  Int J Hematol       Date:  2011-04-05       Impact factor: 2.490

6.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

Authors:  Mary Eapen; Vanderson Rocha; Guillermo Sanz; Andromachi Scaradavou; Mei-Jie Zhang; William Arcese; Anne Sirvent; Richard E Champlin; Nelson Chao; Adrian P Gee; Luis Isola; Mary J Laughlin; David I Marks; Samir Nabhan; Annalisa Ruggeri; Robert Soiffer; Mary M Horowitz; Eliane Gluckman; John E Wagner
Journal:  Lancet Oncol       Date:  2010-07       Impact factor: 41.316

7.  Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.

Authors:  S Carlens; O Ringdén; M Remberger; B Lönnqvist; H Hägglund; S Klaesson; J Mattsson; B M Svahn; J Winiarski; P Ljungman; J Aschan
Journal:  Bone Marrow Transplant       Date:  1998-10       Impact factor: 5.483

8.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

9.  Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Authors:  Stephanie J Lee; John P Klein; A John Barrett; Olle Ringden; Joseph H Antin; Jean-Yves Cahn; Matthew H Carabasi; Robert Peter Gale; Sergio Giralt; Gregory A Hale; Osman Ilhan; Philip L McCarthy; Gerard Socie; Leo F Verdonck; Daniel J Weisdorf; Mary M Horowitz
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

10.  Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.

Authors:  Sergio Giralt; Karen Ballen; Douglas Rizzo; Andreas Bacigalupo; Mary Horowitz; Marcelo Pasquini; Brenda Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

View more
  17 in total

1.  Extracorporeal photopheresis with TC-V in Japanese patients with steroid-resistant chronic graft-versus-host disease.

Authors:  Shinichiro Okamoto; Takanori Teshima; Mizuha Kosugi-Kanaya; Kaoru Kahata; Naomi Kawashima; Jun Kato; Takehiko Mori; Yukiyasu Ozawa; Koichi Miyamura
Journal:  Int J Hematol       Date:  2018-06-29       Impact factor: 2.490

2.  Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation.

Authors:  Junya Kanda; Katsutsugu Umeda; Koji Kato; Makoto Murata; Junichi Sugita; Souichi Adachi; Katsuyoshi Koh; Maiko Noguchi; Hiroaki Goto; Nao Yoshida; Maho Sato; Yuhki Koga; Tsukasa Hori; Yuko Cho; Atsushi Ogawa; Masami Inoue; Yoshiko Hashii; Yoshiko Atsuta; Takanori Teshima
Journal:  Bone Marrow Transplant       Date:  2020-03-11       Impact factor: 5.483

Review 3.  Evolving concepts in prognostic scoring of chronic GvHD.

Authors:  A Lazaryan; M Arora
Journal:  Bone Marrow Transplant       Date:  2017-03-27       Impact factor: 5.483

4.  BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient.

Authors:  Hideki Nakasone; Koji Kawamura; Kimikazu Yakushijin; Akihito Shinohara; Masatsugu Tanaka; Kazuteru Ohashi; Shuichi Ota; Naoyuki Uchida; Takahiro Fukuda; Hirohisa Nakamae; Ken-Ichi Matsuoka; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshihiro Inamoto; Sachiko Seo; Fumihiko Kimura; Masao Ogata
Journal:  Blood Adv       Date:  2019-06-11

Review 5.  Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.

Authors:  Hideki Nakasone; Bita Sahaf; David B Miklos
Journal:  Int J Hematol       Date:  2015-03-27       Impact factor: 2.490

Review 6.  Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.

Authors:  Makoto Murata
Journal:  Int J Hematol       Date:  2015-04-12       Impact factor: 2.490

7.  Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.

Authors:  Hideki Nakasone; Lu Tian; Bita Sahaf; Takakazu Kawase; Kelsi Schoenrock; Spenser Perloff; Christine E Ryan; Jed Paul; Rakesh Popli; Fang Wu; Joanne M Otani; John Coller; Edus H Warren; David B Miklos
Journal:  Blood       Date:  2015-03-12       Impact factor: 22.113

8.  Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.

Authors:  Hideki Nakasone; Mats Remberger; Lu Tian; Petter Brodin; Bita Sahaf; Fang Wu; Jonas Mattsson; Robert Lowsky; Robert Negrin; David B Miklos; Everett Meyer
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

9.  A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey.

Authors:  Rika Sakai; Masataka Taguri; Kumi Oshima; Takehiko Mori; Hiroatsu Ago; Souichi Adachi; Satoshi Morita; Shuichi Taniguchi; Takahiro Fukuda; Kazuteru Ohashi; Tetsuya Eto; Koichi Miyamura; Koji Iwato; Naoki Kobayashi; Heiwa Kanamori; Yasuo Morishima; Tokiko Nagamura-Inoue; Hisashi Sakamaki; Yoshiko Atsuta; Makoto Murata
Journal:  Int J Hematol       Date:  2016-01-22       Impact factor: 2.490

10.  A combined biomarker and clinical panel for chronic graft versus host disease diagnosis.

Authors:  Joseph Pidala; Tara K Sigdel; Anyou Wang; Sue Hsieh; Yoshi Inamoto; Paul J Martin; Mary Ed Flowers; John A Hansen; Stephanie J Lee; Minnie M Sarwal
Journal:  J Pathol Clin Res       Date:  2016-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.